Detalhe da pesquisa
1.
Calcifediol (25-hydroxyvitamin D) improvement and calcium-phosphate metabolism of alendronate sodium/vitamin D3 combination in Chinese women with postmenopausal osteoporosis: a post hoc efficacy analysis and safety reappraisal.
BMC Musculoskelet Disord
; 19(1): 210, 2018 Jul 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29970059
2.
Clinical characteristics associated with bone mineral density improvement after 1-year alendronate/vitamin d3 or calcitriol treatment: Exploratory results from a phase 3, randomized, controlled trial on postmenopausal osteoporotic women in China.
Medicine (Baltimore)
; 97(31): e11694, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-30075569